Our Company


Our Products

Our Technology

Radiation therapy has been used for many decades to treat cancer by using high-energy to destroy rapidly dividing tumour cells. OncoSil™ is a novel and safer form of radiation therapy that is localised to a pancreatic tumour, producing no systemic side effects.



OncoSil Medical’s strategic radiation therapy with a nuclear medicine focus is in three major and distinct unique advantages


OncoSil Medical’s core technology includes the application of radioactive phosphorus (P32) to patients to control tumour growth. The company has spent many years perfecting the production of uniform micro particles (30 micron) that combine a radioactive material with inert silicon.

Share Price ASX: OSL AUD 0.087 as of "12/24/2014"